Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|February 13, 2017
PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneitySarah Croessmann, Hong Yuen Wong, Daniel J Zabransky, et al.
Breast Cancer Research and Treatment|December 12, 2019
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic propertiesKelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, et al.
Oncotarget|December 26, 2015
TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancerHong Yuen Wong, Grace M Wang, Sarah Croessmann, et al.
Cancer Biology & Therapy|December 3, 2010
PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cellsMichaela J Higgins, Julia A Beaver, Hong Yuen Wong, et al.
Molecular and Cellular Biology|November 27, 2013
A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 clusterXiao Ling Li, Toshifumi Hara, Youngeun Choi, et al.
JCO Clinical Cancer Informatics|February 22, 2022
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative ApproachJessica A Lavery, Eva M Lepisto, Samantha Brown, et al.
JAMA Oncology|November 4, 2021
Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic StudiesSamantha Brown, Jessica A Lavery, Ronglai Shen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcomePaula J Hurley, Luigi Marchionni, Brian W Simons, et al.
Molecular & Cellular Proteomics : MCP|October 23, 2025
Proteomic Analysis of PTEN-Deficient Cells Reveals Src-Mediated Upregulation of EphA2 and Therapeutic Potential of Dual InhibitionQiong Wang, Xiangyi Kong, Hongming Song, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 29, 2007
Tamoxifen-stimulated growth of breast cancer due to p21 lossAbde M Abukhdeir, Michele I Vitolo, Pedram Argani, et al.
Pageof 12